Arbilo Co 50/12,5 or 100/25mg FC tablets
Clinical Summary
Quick overview from the medicine insert
Indication
Management of hypertension and reduction of cardiovascular risk in patients with left ventricular hypertrophy.
Dosage (summary)
The usual starting dose is 50 mg of Losartan and 12.5 mg of Hydrochlorothiazide once daily. The dose may be adjusted based on blood pressure response.
Onset of Action / Duration
Antihypertensive effect may be observed within 3 to 6 hours after administration, with peak effects occurring within 6 to 8 hours.
Special Populations
- Elderly patients may require dose adjustment.
- Patients with renal impairment should be monitored closely.
- Patients with hepatic impairment may require dose adjustment.
Pregnancy & Breastfeeding
Use is not recommended during pregnancy, particularly in the second and third trimesters. Caution is advised during lactation.
Key Drug Interactions
- Potassium-sparing diuretics may increase the risk of hyperkalemia.
- Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect.
- Other antihypertensive agents may have additive effects.
Contraindications
- Hypersensitivity to Losartan, Hydrochlorothiazide, or any component of the formulation.
- Severe renal impairment.
- Pregnancy and lactation.
Common side effects
- Dizziness
- Hypotension
- Hyperkalemia
- Fatigue
- Headache
Counselling Points
- Take the medication at the same time each day.
- Monitor blood pressure regularly.
- Report any signs of allergic reaction or severe side effects to a healthcare provider.
- Maintain adequate hydration and avoid excessive potassium intake.
The Arbilo Co 50/12,5 or 100/25mg FC tablets professional information leaflet below is the property of Jubilant Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.